PAM
CDLX icon

Panagora Asset Management’s Cardlytics CDLX Stock Holding History

Panagora Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,906
Closed -$2.03M – 2702
2020
Q2 		$2.03M Buy
+2,906
New +$1.68M 0.01% 670

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Panagora Asset Management's CDLX Position: Q3 2020 in Review

Panagora Asset Management sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 2,906 shares — an estimated $2.03M sold.

Panagora Asset Management first reported a position in CDLX in Q2 2020 and held it in 1 quarter. The position peaked at $2.03M in Q2 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.

  • Panagora Asset Management reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
  • Panagora Asset Management sold 2,906 Cardlytics shares in Q3 2020, an estimated $2.03M.
  • Panagora Asset Management first reported a position in Cardlytics in Q2 2020 and held it in 1 quarter.
  • Panagora Asset Management's Cardlytics position peaked at $2.03M in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.

Based on Panagora Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.